Header image

Session I: Hepatitis C: epidemiology

Tracks
.
Saturday, July 22, 2023
11:15 AM - 1:00 PM
Ballroom 1

Speaker

Dr Rachel Sacks-Davis
Senior Research Fellow
Macfarlane Burnet Institute

Differences in time to HCV treatment initiation following HCV diagnosis in the broad direct-acting antiviral era in five countries

11:15 AM - 11:30 AM

Abstract PDF

Presentation recording

Biography

Doctor Rachel Sacks-Davis is a Research Fellow at the Burnet Institute and the Senior Manager of the International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC).
Dr Zoe Ward
Research Fellow In Infectious Disease Modelling
University Of Bristol

A modelling study of the impact of scaling up of HCV case finding and treatment for people who inject drugs in English region of Bristol and Severn

11:30 AM - 11:45 AM

Abstract PDF

Biography

Zoe is a mathematical biologist interested in infectious disease dynamics and epidemiology. She is currently working on models of Hepatitis C virus in populations of people who inject drugs and the impact of harm reduction policies and treatment in the United Kingdom.
Agenda Item Image
Dr Heather Valerio
Research Fellow
The Kirby Institute, UNSW Sydney

Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study

11:45 AM - 12:00 PM

Abstract PDF

Biography

Heather is a postdoctoral research fellow with the viral hepatitis clinical research program at the Kirby Institute, UNSW Sydney
Ms Rosie Gilliver
Clinical Nurse Consultant
Kirketon Road Centre

Hepatitis C (HCV) reinfection and risk factors among highly marginalised clients of the Kirketon Road Centre, an integrated primary healthcare service in Kings Cross, Sydney

12:00 PM - 12:15 PM

Abstract PDF

Presentation recording

Biography

Rosie is the Clinical Nurse Consultant at the Kirketon Road Centre, where she has expanded hepatitis c care, management and treatment to marginalised communities. Rosie works extensively in clinical care, both in outreach and secondary settings, providing primary care to targeted population groups and co-ordinates the clinical research trials.
Mr Clancy Barrett
Nurse
Qld Health - Tropical Public Health Unit

Preparing for the final phase of elimination: A test-and-treat approach to micro-eliminate hepatitis C in Cairns, Australia.

12:15 PM - 12:20 PM

Abstract PDF

Presentation recording

Biography

Clancy has worked as sexual health and blood borne virus nurse for the past 7 years. He recently moved from the clinical world to the realm of public health as an HIV nurse. He is here at IHCVHEC23 due to working on the Cairns Hep C Free project as a Hepatitis C Community Health nurse for Cairns Sexual Health and is speaking today on behalf of this amazing team who continue this work. He would like to acknowledge and thank the Burnet Institute, UQ, Cairns Sexual Health and the many people involved in the Cairns Hep C Free project.
Dr Amy Kwon
Lecturer
Kirby Institute

Trends in HCV notifications since DAA scale-up: evidence for treatment as prevention?

12:20 PM - 12:25 PM

Abstract PDF

Presentation recording

Biography

Amy Kwon is a mathematician at the Kirby Institute. Her research involves the development of mathematical models to understand the epidemiology of HCV and predict the impact of DAA therapy. She is responsible for providing the key HCV estimates of prevalence and HCV-attributed disease for Australia's Annual Surveillance Report.
A/Prof Behzad Hajarizadeh
Associate Professor
The Kirby Institute, UNSW

Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review

12:25 PM - 12:40 PM

Abstract PDF

Biography

Behzad is a clinical epidemiologist, and an Associate professor in the Kirby Institute (UNSW). He trained as a Medical Practitioner and has a PhD in Medicine. His main areas of research include epidemiology and clinical management of viral hepatitis.
Dr Joanne Carson
Infectious disease and data scientist
Kirby Institute, UNSW

Increasing national trend of direct acting antiviral discontinuation among people treated for hepatitis C virus 2016-2021

12:40 PM - 12:45 PM

Abstract PDF

Biography

Joanne has completed a Bachelor of Science and a Master of Public Health. She is currently undertaking her PhD and is interested in applying novel statistical methods and machine learning to analyse health data.
Agenda Item Image
Ms Annabelle Stevens
Manager
NSW Ministry Of Health

On the way up – making progress towards hepatitis C elimination in NSW

12:45 PM - 1:00 PM

Abstract PDF

Presentation recording

Biography

Annabelle Stevens is a Senior Policy Analyst in the Hepatitis Programs and Policy Unit at NSW Health and is responsible for coordinating the implementation of the NSW HCV Strategy. She is also completing her PhD at the Kirby Institute, UNSW analysing the effectiveness and acceptability of HCV diagnostic testing strategies.

Chairperson

Margaret Hellard
Deputy Director
Burnet Institute

Bianca Prain
Manager
Hepatitis Programs

loading